Title : Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.

Pub. Date : 1995 Sep 1

PMID : 7641199






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synergistic inhibition of hematopoietic tumor growth can be observed in vitro when the iron chelator deferoxamine (DFO) is used in combination with an IgG mAb against the anti-transferrin receptor antibody (ATRA). Deferoxamine transferrin Mus musculus
2 Synergistic inhibition of hematopoietic tumor growth can be observed in vitro when the iron chelator deferoxamine (DFO) is used in combination with an IgG mAb against the anti-transferrin receptor antibody (ATRA). Deferoxamine transferrin Mus musculus